1. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999; 33:1442–1452.
Article
2. Choi BG, Rha SW, Park T, et al. Impact of cigarette smoking: a 3-year clinical outcome of vasospastic angina patients. Korean Circ J. 2016; 46:632–638.
Article
3. Beltrame JF, Crea F, Kaski JC, et al. The who, what, why, when, how and where of vasospastic angina. Circ J. 2016; 80:289–298.
Article
4. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999; 33:1756–1824.
5. Kim KH, Na SH, Park JS. Role of quantitative wall motion analysis in patients with acute chest pain at emergency department. J Cardiovasc Ultrasound. 2017; 25:20–27.
Article
6. Song JK, Park SW, Kim JJ, et al. Values of intravenous ergonovine test with two-dimensional echocardiography for diagnosis of coronary artery spasm. J Am Soc Echocardiogr. 1994; 7:607–615.
Article
7. Song YJ, Ha SJ, Lee DS, et al. Ergonovine stress echocardiography for the diagnosis of vasospastic angina and its prognostic implications in 3,094 consecutive patients. Korean Circ J. 2018; 48:906–916.
Article
8. Ahn JM, Lee KH, Yoo SY, et al. Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol. 2016; 68:137–145.